
The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the recent approval of bevacizumab-awwb, a biosimilar to US-licensed Avastin, marketed as MVASI. MVASI is the first bi...
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer is an episode from FDA Drug Information Updates by ReachMD. Oncologists Dr. Sanjeeve Bala and Dr. Abhilasha Nair from FDA’s Oncology Center of Excellence discuss the rece...
This episode belongs to FDA Drug Information Updates.
Use the player on this page to stream the episode online.
Published Jan 7, 2018, 00:08:29 long, audio available.